Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis 
Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
I.J. Schalk  Clinical Microbiology and Infection 
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Herpes zoster in non-hospitalized children
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era  S. Nunes,
Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study  P. Turner, C.
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding.
Bernard Grenier  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
A. F. Simonetti, C. Garcia-Vidal, D. Viasus, D. García-Somoza, J
Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus  P.-R. Hsueh, L.-M. Huang, P.-J.
Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study 
Louis Pasteur, from crystals of life to vaccination
Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years:
Dermatitis by Dermatophilus congolensis
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Prevalence of Toscana virus antibodies in residents of Croatia
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase.
Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era  S. Nunes,
Vector control: a cornerstone in the malaria elimination campaign
Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel  M. Moschioni, G. De Angelis, S. Melchiorre,
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
I. Al Shukri, F. Hamilton, M. Evans, S. Cooper, G. McKenzie, L
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults*   P. Durando, S.N. Faust,
Metagenomics and probiotics
Previously unknown species of Aspergillus
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate.
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Survival of hepatitis A and E viruses in soil samples
Community-acquired pneumonia: epidemiologic and clinical consideration
M. Daudin, P. Tattevin, B. Lelong, E. Flecher, S. Lavoué, C. Piau, A
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
C.P. Kelly  Clinical Microbiology and Infection 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
J.L. Balcázar  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children  Q. Xu, J.R. Casey, A. Almudevar, M.E. Pichichero  Clinical Microbiology and Infection  Volume 23, Issue 7, Pages 487.e1-487.e6 (July 2017) DOI: 10.1016/j.cmi.2017.01.011 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Mucosal antibody levels were negatively associated with possibility of future episode of Streptococcus pneumoniae acute otitis media (AOM). Nasopharyngeal wash samples were collected from healthy children at 6–24 months of age. Antibody levels were determined by quantitative ELISA and expressed as the ratios of pneumococcal specific to total IgG and total IgA and compared between children who had at least one future episode of AOM 3, 6 and 12 months later and children who did not have any AOM in entire study period. (a) Anti-PhtD IgG; (b) anti-PhtD IgA; (c) anti-PcpA IgG; (d) anti-PcpA IgA; (e) anti-PlyD1 IgG; (f) anti-PlyD1 IgA. Clinical Microbiology and Infection 2017 23, 487.e1-487.e6DOI: (10.1016/j.cmi.2017.01.011) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 2 Mucosal antibody levels were not associated with prevention of future Streptococcus pneumoniae colonization. Nasopharyngeal (NP) wash samples were collected from healthy children at 6–24 months of age. Antibody levels were determined by quantitative ELISA, expressed as the ratios of pneumococcal specific to total IgG and total IgA and compared between children who had future S. pneumoniae colonization and children who did not have future S. pneumoniae colonization 3 and 6 months later. Lines represent GM with 95% CI. (a) 3-month IgG; (b) 3-month IgA; (c) 6-month IgG; (d) 6-month IgA. Clinical Microbiology and Infection 2017 23, 487.e1-487.e6DOI: (10.1016/j.cmi.2017.01.011) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions